Adis Journals
Browse
- No file added yet -

Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons

Download (551.2 kB)
media
posted on 2024-06-26, 16:04 authored by AdisRapid Journals on behalf of:, Walter Reinisch, Gil Y. Melmed, Hiroshi Nakase, Jakob Seidelin, Christopher Ma, Si Xuan, Jacinda Tran, Valencia Remple, Lani Wegrzyn, Gweneth Levy, Yuri Sanchez Gonzalez, Remo Panaccione


 The above interactive infographic represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite). 

History

Usage metrics

    Advances in Therapy

    Categories

    Keywords

    Comparative effectivenessindirect treatment comparisontofacitinibupadacitinibustekinumabvedolizumabinfographicinteractive infographic

    Licence

    CC BY-NC 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC